113 related articles for article (PubMed ID: 12539312)
1. [Effects of hexamethylene bisacetamide on P53 protein expression of MEC-1 cell line and cell differentiation].
Liu B; Situ Z; Wu J; Chen J
Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Feb; 17(1):17-9. PubMed ID: 12539312
[TBL] [Abstract][Full Text] [Related]
2. [Effects of hexamethylene bisacetamide on in vitro adhesion, motility and invasion of human mucoepidermoid carcinoma cell line MEC-1].
Liu B; Wu J; Situ Z
Zhonghua Kou Qiang Yi Xue Za Zhi; 2000 May; 35(3):197-9. PubMed ID: 11780223
[TBL] [Abstract][Full Text] [Related]
3. [Human mucoepidermoid carcinoma MEC-1 cells induced differentiation by HMBA].
Chen Y; SiTu Z; Wu J
Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Jan; 31(1):28-30. PubMed ID: 9275610
[TBL] [Abstract][Full Text] [Related]
4. [Effects of hexamethylene bisacetamide on related genes expression of apoptosis and cell proliferating in human mucoepidermoid carcinoma cell line MEC-1].
Wang L; Wang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Mar; 37(2):120-2. PubMed ID: 12475424
[TBL] [Abstract][Full Text] [Related]
5. [Differentiation effect of hexamethylene bisacetamide (HMBA) on mucoepidermoid carcinoma in vivo].
Jia B; Situ Z; Wu J
Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Mar; 31(2):85-7. PubMed ID: 9387538
[TBL] [Abstract][Full Text] [Related]
6. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA
Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091
[TBL] [Abstract][Full Text] [Related]
7. [Effect of hexamethylene bisacetamine on proliferation and apoptosis of human leukemia cells in vitro and relevant mechanisms].
Yu H; Lu H; Zheng B; Fan H; Xie Y
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):549-52. PubMed ID: 12133503
[TBL] [Abstract][Full Text] [Related]
8. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
Waxman S; Scher BM; Hellinger N; Scher W
Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
[TBL] [Abstract][Full Text] [Related]
9. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells.
Richon VM; Rifkind RA; Marks PA
Cell Growth Differ; 1992 Jul; 3(7):413-20. PubMed ID: 1419904
[TBL] [Abstract][Full Text] [Related]
10. [Differentiation of human hepatocarcinoma SMMC-7721 cells induced by HMBA].
Ouyang GL; Li QF; Peng XX; Hong SG
Shi Yan Sheng Wu Xue Bao; 2001 Dec; 34(4):269-73. PubMed ID: 12549204
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition and differentiation of C6 glioma cells on treatment with hmba.
Shirsat NV; Kayal JJ; Shaikh S; Mehta A
Cell Biol Int; 2001; 25(7):621-7. PubMed ID: 11448101
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line.
Saied IT; Shamsuddin AM
Anticancer Res; 1998; 18(3A):1479-84. PubMed ID: 9673359
[TBL] [Abstract][Full Text] [Related]
13. [Study of effect of mifepristone on apoptosis of human ovarian cancer cell line 3AO].
Li Q; Li JJ; Zhao XB; Ji M
Zhonghua Fu Chan Ke Za Zhi; 2003 Oct; 38(10):625-8. PubMed ID: 14728868
[TBL] [Abstract][Full Text] [Related]
14. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA
Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574
[TBL] [Abstract][Full Text] [Related]
15. Changes in E2F DNA-binding activity during induced erythroid differentiation.
Richon VM; Venta-Perez G
Cell Growth Differ; 1996 Jan; 7(1):31-42. PubMed ID: 8788031
[TBL] [Abstract][Full Text] [Related]
16. Growth and intestinal differentiation are independently regulated in HT29 colon cancer cells.
Schroy PC; Rustgi AK; Ikonomu E; Liu XP; Polito J; Andry C; O'Keane JC
J Cell Physiol; 1994 Oct; 161(1):111-23. PubMed ID: 7929596
[TBL] [Abstract][Full Text] [Related]
17. [Effect of hexamethylene bisacetamide on human gastric cancer cell line SGC-7901].
Xu SW
Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):30-3. PubMed ID: 2194772
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous responses of human colon carcinomas to hexamethylene bisacetamide.
Schroy PC; Carnright K; Winawer SJ; Friedman EA
Cancer Res; 1988 Oct; 48(19):5487-94. PubMed ID: 2458179
[TBL] [Abstract][Full Text] [Related]
19. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
Marks PA; Ramsay R; Sheffery M; Rifkind RA
Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
[TBL] [Abstract][Full Text] [Related]
20. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
Ji YB; Zhou JH; Zuo MX; You QD
Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
